Asia

MaxQ AI announced that its Accipio Ix™ and Accipio Ax™ intracranial hemorrhage detection software will be available on the Nuance® AI Marketplace, the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry’s most widely used radiology reporting platform.

Shuwen Biotech announced that it has been designated as an International Cooperation Base for Novel Biomarkers and Innovative Diagnostic Technologies by authorities in Zhejiang Province, China.

Life sciences companies from across Europe and Asia provide updates on their business and pipelines.

Great Bay Bio is pleased to announce that a strategic cooperation was reached with Guangzhou Boji Medical Biotechnological Co., Ltd. to jointly develop GBB101, a new long-acting injectable biologics for the treatment of anemia caused by Chronic Kidney Disease A new joint venture company has been created to share the R&D achievements of the project, including intellectual property rights and any rights and interests arising in the R&D process.

Comprehensive genomic information of largely understudied Asian populations will expand understanding on the biology of diseases

As an historic lawsuit over opioids was to enter court today, four key defendants reached a settlement.

We round out the month of October and start the month of November with four PDUFA dates on the U.S. Food and Drug Administration’s calendar. Here’s a look.

Two teams and an individual have been awarded this year’s President’s Science and Technology Awards[1][1], the highest honours bestowed upon research scientists and engineers in Singapore whose work have resulted in significant scientific, technological or economic benefits for the country.

On the occasion of the first market partnership for Japan Aalto Bio Reagents launches the first commercially available protein for the detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83.

Companies from across the globe provide business and pipeline updates.